CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02504736
NCT02504736N/ACompleted
CompareCT.gov

24 Week Open Label, Single Arm Study of Colesevelam in High Risk South Asians With Suboptimal LDL-c Levels Despite Maximally Tolerated Statin Therapy

Canadian Collaborative Research Network·observational·Posted Jul 22, 2015·Updated Jan 23, 2020

In Brief

An observational study for Dyslipidemia. Completed, enrolled 90 participants across 1 site.

Detailed Summary

To evaluate the effect of colesevelam on LDL levels and A1c in high-risk , dysglycemic South Asians (with diabetes, and/or with CAD and concomitant metabolic syndrome) whose LDL remains above target despite optimal statin use.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemia
CountriesCanada
CollaboratorsValeant Canada Limited

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 22, 2015
Enrollment StartJun 1, 2015
Primary CompletionFeb 15, 2018
Study CompletionFeb 28, 2018
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 10.9 years ago